{"id":54202,"date":"2026-01-15T14:36:53","date_gmt":"2026-01-15T06:36:53","guid":{"rendered":"https:\/\/flcube.com\/?p=54202"},"modified":"2026-01-15T14:36:55","modified_gmt":"2026-01-15T06:36:55","slug":"sunshine-lake-pharma-launches-ai-powered-protac-platform-to-target-undruggable-proteins","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=54202","title":{"rendered":"Sunshine Lake Pharma Launches AI-Powered PROTAC Platform to Target Undruggable Proteins"},"content":{"rendered":"\n<p><strong>Sunshine Lake Pharma Co., Ltd.<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/6887:HKG\">HKG:\u202f6887<\/a>) announced the launch of an <strong>AI-powered R&amp;D platform<\/strong> focused on the <strong>proteolysis targeting chimera (PROTAC)<\/strong> mechanism, designed to accelerate rational design and clinical translation of PROTAC lead compounds. The platform addresses the <strong>80% of disease-associated human proteins<\/strong> currently considered &#8220;undruggable&#8221; by traditional small-molecule approaches.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-platform-launch\">Platform Launch<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Company<\/strong><\/td><td>Sunshine Lake Pharma Co., Ltd. (HKEX:\u202f6887)<\/td><\/tr><tr><td><strong>Platform Name<\/strong><\/td><td>PROTAC Intelligent R&amp;D Platform<\/td><\/tr><tr><td><strong>Technology Focus<\/strong><\/td><td>AI-driven PROTAC molecule design<\/td><\/tr><tr><td><strong>Core Database<\/strong><\/td><td>HEC-PROTAC DB (high-quality, structured PROTAC-specific database)<\/td><\/tr><tr><td><strong>Launch Date<\/strong><\/td><td>8\u202fJan\u202f2026<\/td><\/tr><tr><td><strong>Key Innovation<\/strong><\/td><td>Systematic integration of molecular structures, degradation activity, physicochemical properties, and PK parameters<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-technology-profile\">Technology Profile<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>PROTAC Mechanism:<\/strong> Leverages cellular <strong>ubiquitin-proteasome system<\/strong> to induce targeted protein degradation, offering <strong>catalytic action<\/strong>, <strong>resistance-overcoming potential<\/strong>, and <strong>lower toxicity<\/strong> vs. traditional inhibitors<\/li>\n\n\n\n<li><strong>Market Gap:<\/strong> <strong>~80% of disease-associated proteins<\/strong> lack suitable binding pockets, making them inaccessible to conventional small molecules<\/li>\n\n\n\n<li><strong>Design Challenges:<\/strong><\/li>\n\n\n\n<li>Complex <strong>ternary complex formation<\/strong> (POI-PROTAC-E3 ligase) requires precise spatial orientation<\/li>\n\n\n\n<li><strong>Fragmented experimental data<\/strong> across patents, literature, and clinical pipelines<\/li>\n\n\n\n<li><strong>Lack of unified standards<\/strong> hinders AI model training<\/li>\n\n\n\n<li>Development remains <strong>heavily reliant on empirical trial-and-error<\/strong><\/li>\n\n\n\n<li><strong>AI Solution:<\/strong> Sunshine\u2019s platform applies <strong>generative AI<\/strong> and <strong>graph neural networks<\/strong> to predict optimal PROTAC architectures, reducing design cycles by an estimated <strong>60\u201170%<\/strong><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-database-amp-ai-integration\">Database &amp; AI Integration<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Data Module<\/th><th>Content<\/th><\/tr><\/thead><tbody><tr><td><strong>Molecular Structures<\/strong><\/td><td>&gt;50,000 PROTAC molecules from patents, literature, and clinical pipelines<\/td><\/tr><tr><td><strong>Degradation Activity<\/strong><\/td><td>DC\u2085\u2080, D_max, t\u00bd degradation kinetics across 200+ targets<\/td><\/tr><tr><td><strong>Physicochemical Properties<\/strong><\/td><td>MW, logP, TPSA, H-bond donors\/acceptors, solubility<\/td><\/tr><tr><td><strong>Pharmacokinetic Parameters<\/strong><\/td><td>CL, Vd, F%, half-life, oral bioavailability data<\/td><\/tr><tr><td><strong>Modular Analysis<\/strong><\/td><td><strong>POI ligand<\/strong> (target binder), <strong>Linker<\/strong> (spatial optimizer), <strong>E3 ligand<\/strong> (ubiquitin recruiter) separately parameterized<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>HEC-PROTAC DB<\/strong> enables <strong>quantitative structure-degradation relationship (QSDR)<\/strong> modeling<\/li>\n\n\n\n<li><strong>AI workflows<\/strong> generate <strong>Linker libraries<\/strong> optimized for ternary complex geometry, <strong>E3 ligand efficiency<\/strong>, and <strong>drug-like properties<\/strong> simultaneously<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-context-amp-competitive-landscape\">Market Context &amp; Competitive Landscape<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Parameter<\/th><th>2026E<\/th><th>2027E<\/th><th>2028E<\/th><\/tr><\/thead><tbody><tr><td><strong>Global PROTAC Market<\/strong><\/td><td>$1.8\u202fbillion<\/td><td>$3.2\u202fbillion<\/td><td>$5.5\u202fbillion<\/td><\/tr><tr><td><strong>AI-Driven PROTAC Share<\/strong><\/td><td>5\u202f%<\/td><td>12\u202f%<\/td><td>25\u202f%<\/td><\/tr><tr><td><strong>Sunshine Platform Value<\/strong><\/td><td>\u00a5500\u202fmillion<\/td><td>\u00a51.2\u202fbillion<\/td><td>\u00a52.8\u202fbillion<\/td><\/tr><tr><td><strong>Pipeline Candidates (est.)<\/strong><\/td><td>3\u202fprograms<\/td><td>6\u202fprograms<\/td><td>10\u202fprograms<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Competitive Landscape:<\/strong><\/li>\n\n\n\n<li><strong>Arvinas (US)<\/strong> and <strong>C4 Therapeutics (US)<\/strong> lead clinical-stage PROTACs (ARV-471, CFT8919) but rely on <strong>traditional med-chem<\/strong><\/li>\n\n\n\n<li><strong>Kymera (US)<\/strong> focuses on IRAK4\/STAT3 with AI assistance but lacks integrated platform<\/li>\n\n\n\n<li><strong>Insilico Medicine (HK)<\/strong> uses AI for degrader design but <strong>no dedicated PROTAC database<\/strong><\/li>\n\n\n\n<li><strong>Sunshine\u2019s Differentiation:<\/strong> <strong>First China-based AI-PROTAC platform<\/strong> with proprietary structured database; <strong>modular AI<\/strong> enables <strong>multi-parameter optimization<\/strong> vs. single-target focus<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-positioning\">Strategic Positioning<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Pipeline Acceleration:<\/strong> Platform targets <strong>oncology<\/strong> (undruggable transcription factors) and <strong>autoimmune<\/strong> (kinase degraders) indications; first IND filing expected <strong>2027<\/strong><\/li>\n\n\n\n<li><strong>Partnership Potential:<\/strong> Sunshine in discussions with <strong>MNCs<\/strong> for <strong>platform licensing<\/strong> (estimated <strong>$50\u201180\u202fmillion<\/strong> upfront per target) and <strong>co-development<\/strong> deals<\/li>\n\n\n\n<li><strong>Technology Moat:<\/strong> <strong>HEC-PROTAC DB<\/strong> is <strong>closed-loop<\/strong> (internal data continuously fed back into AI models), creating <strong>self-reinforcing<\/strong> accuracy improvements<\/li>\n\n\n\n<li><strong>Financial Impact:<\/strong> Platform expected to reduce R&amp;D costs by <strong>\u00a5200\u202fmillion\/year<\/strong> and shorten preclinical timelines from <strong>48\u202fmonths to 18\u202fmonths<\/strong><\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding Sunshine Lake Pharma\u2019s AI platform capabilities, pipeline advancement, and market positioning. Actual results may differ due to AI model accuracy, target tractability, competitive dynamics, and regulatory acceptance of AI-designed molecules.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/2026011401200_c.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of 2026011401200_c.\"><\/object><a id=\"wp-block-file--media-81b916a2-85f5-48ae-891b-eb24597eeb71\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/2026011401200_c.pdf\">2026011401200_c<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/2026011401200_c.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-81b916a2-85f5-48ae-891b-eb24597eeb71\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Sunshine Lake Pharma Co., Ltd. (HKG:\u202f6887) announced the launch of an AI-powered R&amp;D platform focused&#8230;<\/p>\n","protected":false},"author":1,"featured_media":54207,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,93],"tags":[99,4190,2054,70],"class_list":["post-54202","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-digital","tag-ai","tag-hkg-6887","tag-sunshine-lake-pharma","tag-tpd"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Sunshine Lake Pharma Launches AI-Powered PROTAC Platform to Target Undruggable Proteins - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Sunshine Lake Pharma Co., Ltd. (HKG:\u202f6887) announced the launch of an AI-powered R&amp;D platform focused on the proteolysis targeting chimera (PROTAC) mechanism, designed to accelerate rational design and clinical translation of PROTAC lead compounds. The platform addresses the 80% of disease-associated human proteins currently considered &quot;undruggable&quot; by traditional small-molecule approaches.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=54202\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sunshine Lake Pharma Launches AI-Powered PROTAC Platform to Target Undruggable Proteins\" \/>\n<meta property=\"og:description\" content=\"Sunshine Lake Pharma Co., Ltd. (HKG:\u202f6887) announced the launch of an AI-powered R&amp;D platform focused on the proteolysis targeting chimera (PROTAC) mechanism, designed to accelerate rational design and clinical translation of PROTAC lead compounds. The platform addresses the 80% of disease-associated human proteins currently considered &quot;undruggable&quot; by traditional small-molecule approaches.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=54202\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-15T06:36:53+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-15T06:36:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/1503.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54202#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54202\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Sunshine Lake Pharma Launches AI-Powered PROTAC Platform to Target Undruggable Proteins\",\"datePublished\":\"2026-01-15T06:36:53+00:00\",\"dateModified\":\"2026-01-15T06:36:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54202\"},\"wordCount\":513,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54202#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/1503.webp\",\"keywords\":[\"AI\",\"HKG: 6887\",\"Sunshine Lake Pharma\",\"TPD\"],\"articleSection\":[\"Company\",\"Digital\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=54202#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54202\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=54202\",\"name\":\"Sunshine Lake Pharma Launches AI-Powered PROTAC Platform to Target Undruggable Proteins - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54202#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54202#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/1503.webp\",\"datePublished\":\"2026-01-15T06:36:53+00:00\",\"dateModified\":\"2026-01-15T06:36:55+00:00\",\"description\":\"Sunshine Lake Pharma Co., Ltd. (HKG:\u202f6887) announced the launch of an AI-powered R&D platform focused on the proteolysis targeting chimera (PROTAC) mechanism, designed to accelerate rational design and clinical translation of PROTAC lead compounds. The platform addresses the 80% of disease-associated human proteins currently considered \\\"undruggable\\\" by traditional small-molecule approaches.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54202#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=54202\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54202#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/1503.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/1503.webp\",\"width\":1080,\"height\":608,\"caption\":\"Sunshine Lake Pharma Launches AI-Powered PROTAC Platform to Target Undruggable Proteins\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54202#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sunshine Lake Pharma Launches AI-Powered PROTAC Platform to Target Undruggable Proteins\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Sunshine Lake Pharma Launches AI-Powered PROTAC Platform to Target Undruggable Proteins - Insight, China&#039;s Pharmaceutical Industry","description":"Sunshine Lake Pharma Co., Ltd. (HKG:\u202f6887) announced the launch of an AI-powered R&D platform focused on the proteolysis targeting chimera (PROTAC) mechanism, designed to accelerate rational design and clinical translation of PROTAC lead compounds. The platform addresses the 80% of disease-associated human proteins currently considered \"undruggable\" by traditional small-molecule approaches.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=54202","og_locale":"en_US","og_type":"article","og_title":"Sunshine Lake Pharma Launches AI-Powered PROTAC Platform to Target Undruggable Proteins","og_description":"Sunshine Lake Pharma Co., Ltd. (HKG:\u202f6887) announced the launch of an AI-powered R&D platform focused on the proteolysis targeting chimera (PROTAC) mechanism, designed to accelerate rational design and clinical translation of PROTAC lead compounds. The platform addresses the 80% of disease-associated human proteins currently considered \"undruggable\" by traditional small-molecule approaches.","og_url":"https:\/\/flcube.com\/?p=54202","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-01-15T06:36:53+00:00","article_modified_time":"2026-01-15T06:36:55+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/1503.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=54202#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=54202"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Sunshine Lake Pharma Launches AI-Powered PROTAC Platform to Target Undruggable Proteins","datePublished":"2026-01-15T06:36:53+00:00","dateModified":"2026-01-15T06:36:55+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=54202"},"wordCount":513,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=54202#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/1503.webp","keywords":["AI","HKG: 6887","Sunshine Lake Pharma","TPD"],"articleSection":["Company","Digital"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=54202#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=54202","url":"https:\/\/flcube.com\/?p=54202","name":"Sunshine Lake Pharma Launches AI-Powered PROTAC Platform to Target Undruggable Proteins - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=54202#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=54202#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/1503.webp","datePublished":"2026-01-15T06:36:53+00:00","dateModified":"2026-01-15T06:36:55+00:00","description":"Sunshine Lake Pharma Co., Ltd. (HKG:\u202f6887) announced the launch of an AI-powered R&D platform focused on the proteolysis targeting chimera (PROTAC) mechanism, designed to accelerate rational design and clinical translation of PROTAC lead compounds. The platform addresses the 80% of disease-associated human proteins currently considered \"undruggable\" by traditional small-molecule approaches.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=54202#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=54202"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=54202#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/1503.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/1503.webp","width":1080,"height":608,"caption":"Sunshine Lake Pharma Launches AI-Powered PROTAC Platform to Target Undruggable Proteins"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=54202#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Sunshine Lake Pharma Launches AI-Powered PROTAC Platform to Target Undruggable Proteins"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/1503.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/54202","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=54202"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/54202\/revisions"}],"predecessor-version":[{"id":54208,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/54202\/revisions\/54208"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/54207"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=54202"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=54202"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=54202"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}